Primary Signet-ring Cell Carcinoma of the Urinary Bladder: A Clinicopathologic and Immunohistochemical Study of 5 Cases

Primary signet-ring cell carcinoma of the urinary bladder is a rare histologic variant of adenocarcinoma. Generally, this neoplasm occurs in middle age and the clinical presentation does not differ from the most frequent transitional cell carcinomas. The prognosis is frequently poor as at diagnosis it is often in an advanced phase. It is essential to distinguish this carcinoma from metastases, as different therapeutic strategies are often necessary. We present 5 cases of primary signet-ring cell carcinoma of the urinary bladder and we used a panel of histochemical and immunohistochemical markers for differential diagnosis from secondary carcinoma in an attempt to elucidate the histogenetic derivation of this neoplasia.

[1]  M. Fujita,et al.  [Primary signet-ring cell carcinoma of the urinary bladder: a case report]. , 2009, Hinyokika kiyo. Acta urologica Japonica.

[2]  R. Shah,et al.  Prostate-specific antigen, high-molecular-weight cytokeratin (clone 34betaE12), and/or p63: an optimal immunohistochemical panel to distinguish poorly differentiated prostate adenocarcinoma from urothelial carcinoma. , 2006, American journal of clinical pathology.

[3]  G. Nesi,et al.  Immunohistochemistry in the Differential Diagnosis Between Primary and Secondary Intestinal Adenocarcinoma of the Urinary Bladder , 2005, Applied immunohistochemistry & molecular morphology : AIMM.

[4]  W. Murphy,et al.  Tumors of the kidney, bladder, and related urinary structures , 2004 .

[5]  P. Chu,et al.  Immunohistochemical characterization of signet-ring cell carcinomas of the stomach, breast, and colon. , 2004, American journal of clinical pathology.

[6]  J. Alroy,et al.  Primary adenocarcinomas of the human urinary bladder: Histochemical, immunological and ultrastructural studies , 2004, Virchows Archiv A.

[7]  P. Dahm,et al.  Malignant non-urothelial neoplasms of the urinary bladder: a review. , 2003, European urology.

[8]  M. Varma,et al.  High molecular weight cytokeratin antibody (clone 34βE12): a sensitive marker for differentiation of high‐grade invasive urothelial carcinoma from prostate cancer , 2003, Histopathology.

[9]  P. Tamboli,et al.  Colonic adenocarcinoma metastatic to the urinary tract versus primary tumors of the urinary tract with glandular differentiation: a report of 7 cases and investigation using a limited immunohistochemical panel. , 2002, Archives of pathology & laboratory medicine.

[10]  E. Kunze,et al.  Histogenesis of nonurothelial carcinomas of the urinary bladder from pre-existent transitional cell carcinomas. A histopathological and immunohistochemical study , 2002, Urological Research.

[11]  P. Tamboli,et al.  Primary Signet-Ring Cell Carcinoma of Lung: Immunohistochemical Study and Comparison With Non-Pulmonary Signet-Ring Cell Carcinomas , 2001, The American journal of surgical pathology.

[12]  Ximing J. Yang,et al.  Immunohistochemical Distinction Between Primary Adenocarcinoma of the Bladder and Secondary Colorectal Adenocarcinoma , 2001, The American journal of surgical pathology.

[13]  M. Tachibana,et al.  Primary signet‐ring cell carcinoma of the urinary bladder inducing renal failure , 2001, International journal of urology : official journal of the Japanese Urological Association.

[14]  N. Goldstein,et al.  Colon Signet Ring Cell Adenocarcinoma: Immunohistochemical Characterization and Comparison with Gastric and Typical Colon Adenocarcinomas , 2000, Applied immunohistochemistry & molecular morphology : AIMM.

[15]  K. Nakanishi,et al.  Mucin histochemistry in primary adenocarcinoma of the urinary bladder (of urachal or vesicular origin) and metastatic adenocarcinoma originating in the colorectum , 2000, Pathology international.

[16]  Bates,et al.  Secondary neoplasms of the bladder are histological mimics of nontransitional cell primary tumours: clinicopathological and histological features of 282 cases , 2000, Histopathology.

[17]  T. Tot.  The role of cytokeratins 20 and 7 and estrogen receptor analysis in separation of metastatic lobular carcinoma of the breast and metastatic signet ring cell carcinoma of the gastrointestinal tract , 2000, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[18]  N. Ordóñez.  Thrombomodulin expression in transitional cell carcinoma. , 1998, American journal of clinical pathology.

[19]  M. Becich,et al.  Prostatic carcinoma with signet ring cells: a clinicopathologic and immunohistochemical analysis of 12 cases, with review of the literature. , 1998, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[20]  Van Diest,et al.  Value of a panel of antibodies to identify the primary origin of adenocarcinomas presenting as bladder carcinoma , 1998, Histopathology.

[21]  渡辺 晋一.  Dr. Richard Rox Anderson , 1997 .

[22]  N. Ordóñez.  Value of thrombomodulin immunostaining in the diagnosis of transitional cell carcinoma: a comparative study with carcinoembryonic antigen , 1997, Histopathology.

[23]  J. Palazzo,et al.  Reciprocity between membranous and nuclear expression of β-catenin in colorectal tumours , 1997, Virchows Archiv.

[24]  K. Wojno.  Tumors of the Kidney, Bladder, and Related Urinary Structures. , 1996 .

[25]  D. Newling,et al.  Primary signet‐ring cell carcinoma of the urinary bladder , 1996, Histopathology.

[26]  T. Esen,et al.  Primary signet ring cell carcinoma of the urinary bladder. Review of the literature and report of two cases. , 1995, Urologia internationalis.

[27]  L. McWilliam,et al.  A study of vesical adenocarcinoma, intestinal metaplasia and related lesions using mucin histochemistry , 1990, Histopathology.

[28]  R. Young,et al.  Serous adenocarcinoma of the uterus metastatic to the urinary bladder mimicking primary bladder neoplasia. A report of a case. , 1990, The American journal of surgical pathology.

[29]  P. Carroll,et al.  Primary signet-ring cell carcinoma of urinary bladder. , 1989, Urology.

[30]  R. Moll,et al.  Villin: a cytoskeletal protein and a differentiation marker expressed in some human adenocarcinomas , 1987, Virchows Archiv. B, Cell pathology including molecular pathology.

[31]  F. Dreffke,et al.  [Signet-ring cell carcinoma of the urinary bladder]. , 1987, Zeitschrift fur Urologie und Nephrologie.

[32]  F. Kuhajda,et al.  Prostate-specific acid phosphatase immunoreactivity in adenocarcinomas of the urinary bladder. , 1986, Human pathology.

[33]  J. Epstein,et al.  Keratin and epithelial membrane antigen immunoreactivity in nonneoplastic fibrous pleural lesions: implications for the diagnosis of desmoplastic mesothelioma. , 1986, Human pathology.

[34]  J. Epstein,et al.  Adenocarcinoma of the prostate with endometrioid features. A light microscopic and immunohistochemical study of ten cases , 1986, Cancer.

[35]  K. Anderson,et al.  Mucin histochemistry of cystitis glandularis and primary adenocarcinoma of the urinary bladder. , 1985, Archives of pathology & laboratory medicine.

[36]  Majid Ali,et al.  Primary signet‐ring cell carcinoma of the urinary bladder: Review of the literature and report of a case , 1981, Cancer.

[37]  Tiltman Aj,et al.  Adenocarcinoma of the urinary bladder. Histochemical distinction between urachal and metastatic carcinomas. , 1977 .

[38]  A. Tiltman,et al.  Adenocarcinoma of the urinary bladder. Histochemical distinction between urachal and metastatic carcinomas. , 1977, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[39]  P. Edwards,et al.  Conversion of cystitis glandularis to adenocarcinoma. , 1972, The Journal of urology.

[40]  M. Melicow.  Tumors of the urinary bladder: a clinico-pathological analysis of over 2500 specimens and biopsies. , 1955, The Journal of urology.

[41]  A. Dean,et al.  Mucous adenocarcinoma of the urinary bladder , 1955, Cancer.

[42]  F. Mostofi,et al.  Potentialities of bladder epithelium. , 1954, The Journal of urology.